Impact of covid-19 pandemic on gastroenterology: Chronic gastroenterological diseases, iatrogenesis and endoscopy.

The current article describes the course and treatment of chronic gastrointestinal diseases during the COVID-19 pandemic. We analyzed articles about iatrogenic harm to the gastrointestinal tract by etiological and pathogenetic therapy of the COVID-19. National and international recommendations for gastrointestinal endoscopy for infected and uninfected patients are analyzed.Copyright © A.M. SHCHIKOTA, I.V. POGONCHENKOVA, E.A. TUROVA, M.A. RASSULOVA, M.S. FILIPPOV.

Gastrointestinal tract, liver, and pancreas affected by covid-19.

We reviewed literature about the effects of novel coronavirus disease COVID-19 on the digestive system. The review ses the pathogenesis, the natural history, and the frequency of gastrointestinal and hepatobiliary complications in patientCOVID-19. We briefly overviewed therapy for intestinal, liver, and pancreatic damage by COVID-19.Copyright © 2021, Media Sphera Publishing Group. All rights reserved.

[Capacity of vibroacoustic therapy for correction of respiratory manifestations of post COVID-19 syndrome]. / Vozmozhnosti vibroakusticheskoi terapii v korrektsii respiratornykh proyavlenii postkovidnogo sindroma.

The search for therapeutic strategies for the correction of post COVID-19 syndrome is an urgent task of medicine. One of the frequent manifestations of post COVID-19 syndrome is the prolonged persistence of respiratory syndromes - dyspnea and cough. Vibroacoustic therapy is promising methods in the complex effect on broncho-pulmonary symptoms of COVID-19. OBJECTIVE: To study the effect of vibroacoustic pulmonary therapy implemented through the BARK VibroLUNG apparatus on the clinical and instrumental parameters of patients undergoing COVID-19 with residual respiratory symptoms. MATHERIAL AND METHODS: The effect of vibroacoustic therapy (5-day course of 2 sessions) on dyspnea and cough and respiratory function in 60 patients aged 18 to 75 years who underwent COVID-19 of varying severity for more than 12 weeks before the start of the study, with the presence of distant respiratory symptoms, was investigated. Patients were divided into two equal and age-matched groups - without (1st) and with (2nd) chronic bronchopulmonary pathology. RESULTS: Analysis of comorbidity of patients with respiratory phenotype of post COVID-19 syndrome showed frequent presence of concomitant cardiovascular pathology (76.7%). The predominant patient complaint was dyspnea (93.3% in both groups): 29 patients (96.7%) in the non-lung group, and 27 patients (90%) in the chronic lung group. The mean mMRC dyspnea score for all patients was 1.1±0.49 points (1.2±0.5 points in the first group and 1.0±0.45 points in the second group). Cough was observed less often - in 18 patients of both groups (30%), mainly in the second group. During the course of vibroacoustic therapy in the 1st group, the number of patients with dyspnea decreased from 96.7 to 30%, in the 2nd group - from 90 to 10%, the total mean mMRC dyspnea score decreased to 0.2±0.4 (Δ 82%), and a complete regression of cough syndrome was achieved in both groups. Also, an increase in forced expiratory volume in 1st second and peak expiratory flow indicators was revealed both in the general group of patients and in the group of patients without chronic lung pathology. CONCLUSION: The results obtained during the study of the use of vibroacoustic therapy in patients with respiratory manifestations of post-COVID syndrome, including the presence of chronic bronchopulmonary pathology, allow us to conclude on the effective correction of dyspnea and cough during treatment. Vibroacoustic therapy is a promising non-drug method of exposure to bronchopulmonary manifestations of post-COVID syndrome in patients during rehabilitation.

Impact of covid-19 pandemic on gastroenterology: Chronic gastroenterological diseases, iatrogenesis and endoscopy

The current article describes the course and treatment of chronic gastrointestinal diseases during the COVID-19 pandemic. We analyzed articles about iatrogenic harm to the gastrointestinal tract by etiological and pathogenetic therapy of the COVID-19. National and international recommendations for gastrointestinal endoscopy for infected and uninfected patients are analyzed. © A.M. SHCHIKOTA, I.V. POGONCHENKOVA, E.A. TUROVA, M.A. RASSULOVA, M.S. FILIPPOV.

Gastrointestinal tract, liver, and pancreas affected by covid-19

We reviewed literature about the effects of novel coronavirus disease COVID-19 on the digestive system. The review ses the pathogenesis, the natural history, and the frequency of gastrointestinal and hepatobiliary complications in patientCOVID-19. We briefly overviewed therapy for intestinal, liver, and pancreatic damage by COVID-19. © 2021, Media Sphera Publishing Group. All rights reserved.

Cardiological Rehabilitation and COVID-19 Pandemic: Literature Review

Objective of the Review: To review literature data on the need for cardiological rehabilitation of COVID-19 survivors and the features of rehabilitation of patients with cardiovascular pathologies during pandemic. Key Points. SARS-CoV-2 virus uses several cardiotropic mechanisms and can damage the myocardium. The COVID-19 pandemic can result in an increase in the number of patients with acute and chronic cardiological pathologies who require rehabilitation. Traditional cardiological rehabilitation has a limited range of measures during a pandemic;the majority of experts recommend rehabilitation at home and using telemedicine. Conclusion. COVID-19 survivors can need cardiological rehabilitation. Remote management is a key trend in cardiological rehabilitation during a pandemic. Цель обзора: анализ литературных данных о потребности в кардиореабилитации у больных, перенесших COVID-19, и особенностях реабилитации пациентов с сердечно-сосудистой патологией в период пандемии. Основные положения. Вирус SARS-CoV-2 имеет несколько механизмов кардиотропного действия и может вызывать повреждение миокарда. В результате пандемии COVID-19 возможно увеличение числа пациентов с острой и хронической кардиологической патологией, нуждающихся в реабилитации. Возможности традиционной кардиологической реабилитации в условиях пандемии ограничены;большинство экспертов рекомендуют реабилитацию в домашних условиях и использование телемедицинских технологий. Заключение. Пациенты, перенесшие COVID-19, потенциально нуждаются в проведении кардиореабилитации. Применение дистанционных методов является основным вектором развития кардиологической реабилитации в период пандемии.

Chronic obstructive lung disease and COVID-19: Topical issues

The problem of comorbidity of new coronaviral infection (COVID-19) and chronic obstructive pulmonary disease (COPD) is acute, considering similarity of clinical manifestations, diagnostic difficulties, the potential severe disease course. Patients with COPD represent a vulnerable group of infected SARS-CoV-2, with a complicated disease course and frequent adverse outcome. Features of the spread of the virus limit treatment and diagnosis for patients with COPD, making it difficult to provide medical care during the pandemic. The negative results of some clinical studies of antiviral drugs for patients with COVID-19 indicate the need for a search for new drugs;for this reason, analysis of the anti-inflammatory effect on the lungs in infection COVID-19 of drugs of basic COPD therapy is promising. © 2020 Medical Education. All rights reserved.